Why the study?
Widespread availability of smart devices can yield misleading recordings, making it important to review photoplethysmography-based devices studied to date for AF detection.
While photoplethysmography-based smart devices show potential for detecting silent atrial fibrillation, their widespread use may lead to false positives and unnecessary anxiety, highlighting the need to identify the most accurate devices.
Caution against routine photoplethysmography screening due to false positives; leaves open which devices merit validation for silent AF.
Atrial fibrillation is the most commonly experienced type of cardiac arrhythmia and is the most associated with substantial clinical occurrences and expenses. This arrhythmia often occurs in its "silent" asymptomatic form, revealed only after complications such as a stroke or congestive heart failure have transpired. New smart devices confer effective advantages in the detection of this heart arrhythmia, of which photoplethysmography-based smart devices have shown great potential, according to previous research. However, the solution becomes a problem as widespread use and high availability of various applications and smart devices may lead to substantial amounts of false and misleading recordings and information, causing unnecessary anxiety regarding arrhythmic occurrences diagnosed by the devices but not professionally confirmed. Thus, with most of the devices being photoplethysmography based for detection of atrial fibrillation, it is important to research devices studied up to this point to find the best smart device to detect the aforementioned arrhythmias.
No takes yet. Share an insight, caveat, or question.
Sijerčić et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: